Is EZUF NL B.V. FDA approved?

EZUF NL B.V. holds 1 FDA-registered establishment in the Netherlands. Registration puts a site on the FDA's register and open to inspection; it is not an approval of the company. Approvals attach to individual drug applications.

Where are EZUF NL B.V.'s drugs manufactured?

The FDA register lists Eijsden. Registered operations: active ingredient (API) manufacture, labelling.

What drugs does EZUF NL B.V. make?

17 products are listed under EZUF NL B.V. in the openFDA NDC Directory, most often as liquid; powder. The full breakdown by dosage form and route is above. A listing count is not a sales figure.

EZUF NL B.V.

Data as of 24 Sept 2026 · How to read this entry

Request a quote Claim this profile

Registered sites: 1
Active NDC listings: 17
Labeller names: 2
Live patents: 0
Countries: 1
Base: Netherlands

Authorisation

Registered operations

Active ingredient (API) manufacture1Labelling1

Sites

Registered establishments

Establishment	Address	Registered for	FEI / DUNS
EZUF NL B.V.	Muggenweg 2, Eijsden, Limbourg 6245AB, Netherlands (NLD)	Active ingredient (API) manufacture, Labelling	3016994900492902187

Catalogue

Drug listings by form and route

17 active NDC listings: 17 drug for further processing. By marketing category: DRUG FOR FURTHER PROCESSING 17.

Dosage form	NDCs
liquid	11
powder	6

Route	NDCs

Labeller name on the listing	NDCs
ezuf nl b.v.	15
ezuf nl b.v	2

Catalogue

Marketed products

Brand	Generic name	Form / route	NDC
-	Dispersion of Zinc Oxide	liquid	15613-502DRUG FOR FURTHER PROCESSING
-	Dispersion of Zinc Oxide	liquid	15613-506DRUG FOR FURTHER PROCESSING
-	Dispersion of Zinc Oxide	liquid	15613-509DRUG FOR FURTHER PROCESSING
-	Dispersion of Zinc Oxide	liquid	15613-510DRUG FOR FURTHER PROCESSING
-	Dispersion of Zinc Oxide	liquid	15613-511DRUG FOR FURTHER PROCESSING
-	Dispersion of Zinc Oxide and Titanium Dioxide	liquid	15613-504DRUG FOR FURTHER PROCESSING
-	Dispersion of Zinc Oxide and Titanium Dioxide	liquid	15613-505DRUG FOR FURTHER PROCESSING
-	Dispersion of Zinc oxdie	liquid	15613-508DRUG FOR FURTHER PROCESSING
-	Dispersion of Zinc oxide	liquid	15613-507DRUG FOR FURTHER PROCESSING
-	Zinc oxide	powder	15613-310DRUG FOR FURTHER PROCESSING
-	Zinc oxide	powder	15613-600DRUG FOR FURTHER PROCESSING
-	Zinc oxide	powder	15613-610DRUG FOR FURTHER PROCESSING
-	Zinc oxide dispersion	liquid	15613-501DRUG FOR FURTHER PROCESSING
-	Zinc oxide dispersion	liquid	15613-512DRUG FOR FURTHER PROCESSING
-	zinc oxide	powder	15613-100DRUG FOR FURTHER PROCESSING
-	zinc oxide	powder	15613-110DRUG FOR FURTHER PROCESSING
-	zinc oxide	powder	15613-300DRUG FOR FURTHER PROCESSING

Neighbours

Registered in the same town

EverZinc Nederland B.V.Eijsden, NLD

Compare

Comparable companies in Netherlands

Fagron Services B.V.1 site · 75 NDC
Aspen Oss B.V.1 site · 46 NDC
Laboratorium Ofichem BV1 site · 21 NDC
B.V. KATWIJK CHEMIE1 site · 13 NDC
Dow Benelux B.V.1 site · 8 NDC
EverZinc Nederland B.V.1 site · 4 NDC
Niacet b.v.1 site · 2 NDC
BioChem Oss B.V.1 site · 1 NDC
Hepac B.V.1 site · 1 NDC
Purac Biochem B.V.1 site · 1 NDC

Enquiry

Common questions

Is EZUF NL B.V. FDA approved?: EZUF NL B.V. holds 1 FDA-registered establishment in the Netherlands. Registration puts a site on the FDA's register and open to inspection; it is not an approval of the company. Approvals attach to individual drug applications.
Where are EZUF NL B.V.'s drugs manufactured?: The FDA register lists Eijsden. Registered operations: active ingredient (API) manufacture, labelling.
What drugs does EZUF NL B.V. make?: 17 products are listed under EZUF NL B.V. in the openFDA NDC Directory, most often as liquid; powder. The full breakdown by dosage form and route is above. A listing count is not a sales figure.

Compiled from FDA establishment registrations, the openFDA NDC Directory, the Orange Book and the FDA drug shortage database. Not claimed by the company. Sources and methodology.